The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer
Open accessAbstract
This review addresses the role of H. pylori and the effect of H. pylori eradication on gastritis, peptic ulcer disease, atrophic gastritis and gastric cancer. Specific emphasis is given to various factors that influence the clinical course of this infection. H. pylori induces chronic gastritis in virtually all infected subjects. This inflammation can lead to peptic ulceration and atrophic gastritis in a considerable number of infected subjects. A minority eventually develops gastric cancer. The risk of such complications depends upon the severity of gastritis, which is determined by various host‐ and bacteria‐related factors. Among bacterial factors, most of the evidence addresses the cagA pathogenicity island, the presence of which has been associated with more severe gastritis, peptic ulceration, atrophic gastritis and gastric cancer. Among host factors, most of the evidence focuses on acid production in response to H. pylori infection. An increase in acid secretion limits H. pylori gastritis to the antrum at the risk of duodenal ulcer disease; a reduction allows more proximal inflammation at the risk of atrophic gastritis, gastric ulcer disease, and gastric cancer. Gastritis and atrophy negatively influence acid secretion. H. pylori eradication is required in peptic ulcer disease and may be advocated in patients on profound acid suppressive therapy; it has been shown to cure gastritis and prevent ulcer recurrence. Further study is required to determine the efficacy of H. pylori eradication in the primary and secondary prevention of atrophic gastritis and gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A model for gastric cancer epidemiology
CORREA, P. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90498-5 · Cited by 1,158
Cited by
Diagnosis of Helicobacter pylori infection: Current options and developments
Wang, Y.-K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11221 · Cited by 466
Helicobacter pylori treatment: antibiotics or probiotics
Goderska, K., Agudo Pena, S., & Alarcon, T. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8535-7 · Cited by 288
Diagnosis of Helicobacter pylori: What should be the gold standard?
Patel, S. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12847 · Cited by 284
Harris, S. A., & Harris, E. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142853 · Cited by 279
Assembly and glycosylation of Helicobacter pylori sheathed flagella
Kumar, R., Tachiyama, S., Yu, H., Heydari, S., Guo, J., Botting, J. M., Guo, W., Hoover, T. R., & Liu, J. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag011 · Cited by 6
Metadata
- Authors
- KUIPERS, E. J.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1997-04
- Volume
- 11
- Issue
- S1
- Pages
- 71-88
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2082018820
- Cited by
- 220
- References
- 1
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. https://app.cochat.ai/papers/10.1046/j.1365-2036.11.s1.5.x
- The paper
- KUIPERS, E. J. (1997). Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.11.s1.5.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.